357 related articles for article (PubMed ID: 2233723)
1. An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
Kato GJ; Barrett J; Villa-Garcia M; Dang CV
Mol Cell Biol; 1990 Nov; 10(11):5914-20. PubMed ID: 2233723
[TBL] [Abstract][Full Text] [Related]
2. Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization.
Dang CV; Barrett J; Villa-Garcia M; Resar LM; Kato GJ; Fearon ER
Mol Cell Biol; 1991 Feb; 11(2):954-62. PubMed ID: 1990293
[TBL] [Abstract][Full Text] [Related]
3. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
[TBL] [Abstract][Full Text] [Related]
4. B-myc inhibits neoplastic transformation and transcriptional activation by c-myc.
Resar LM; Dolde C; Barrett JF; Dang CV
Mol Cell Biol; 1993 Feb; 13(2):1130-6. PubMed ID: 8423780
[TBL] [Abstract][Full Text] [Related]
5. Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping.
Penn LJ; Brooks MW; Laufer EM; Littlewood TD; Morgenstern JP; Evan GI; Lee WM; Land H
Mol Cell Biol; 1990 Sep; 10(9):4961-6. PubMed ID: 2201910
[TBL] [Abstract][Full Text] [Related]
6. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation.
Brough DE; Hofmann TJ; Ellwood KB; Townley RA; Cole MD
Mol Cell Biol; 1995 Mar; 15(3):1536-44. PubMed ID: 7862146
[TBL] [Abstract][Full Text] [Related]
7. A point mutation in the MyoD basic domain imparts c-Myc-like properties.
Van Antwerp ME; Chen DG; Chang C; Prochownik EV
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9010-4. PubMed ID: 1329087
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains.
Abate C; Luk D; Curran T
Mol Cell Biol; 1991 Jul; 11(7):3624-32. PubMed ID: 1904542
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic activity of the c-Myc protein requires dimerization with Max.
Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein.
Dang CV; McGuire M; Buckmire M; Lee WM
Nature; 1989 Feb; 337(6208):664-6. PubMed ID: 2645525
[TBL] [Abstract][Full Text] [Related]
11. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu W; Cechova K; Tassi V; Dalla-Favera R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
[TBL] [Abstract][Full Text] [Related]
12. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
Blackwood EM; Eisenman RN
Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410
[TBL] [Abstract][Full Text] [Related]
13. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
Hann SR; Dixit M; Sears RC; Sealy L
Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
[TBL] [Abstract][Full Text] [Related]
14. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
15. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
16. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
18. Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1.
Cziepluch C; Wenzel A; Schürmann J; Schwab M
Oncogene; 1993 Oct; 8(10):2833-8. PubMed ID: 8378092
[TBL] [Abstract][Full Text] [Related]
19. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
Katzav S; Cleveland JL; Heslop HE; Pulido D
Mol Cell Biol; 1991 Apr; 11(4):1912-20. PubMed ID: 2005887
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
Min S; Mascarenhas NT; Taparowsky EJ
Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]